Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Luteinizing Hormone
100%
Recurrent Anaphylaxis
100%
Menstruating Women
100%
Idiopathic Anaphylaxis
33%
Placebo
16%
Illness
16%
Remission
16%
Non-responders
16%
Recurring
16%
Adverse Reactions
16%
Medroxyprogesterone
16%
Progesterone Secretion
16%
Anaphylactoid
16%
Anaphylactoid Reaction
16%
Ovarian Suppression
16%
Intradermal Injection
16%
Unknown Cause
16%
Endogenous Progesterone
16%
Double-blind Trial
16%
Nursing and Health Professions
Anaphylaxis
100%
Gonadorelin Agonist
100%
Gonadorelin
40%
Placebo
20%
Infusion
20%
Remission
20%
Progesterone
20%
Adverse Drug Reaction
20%
Medroxyprogesterone
20%
Intradermal Drug Administration
20%
Gonadorelin Derivative
20%
Diseases
20%
Medicine and Dentistry
Anaphylaxis
100%
Gonadorelin Agonist
100%
Gonadorelin
40%
Placebo
20%
Infusion
20%
Progesterone Release
20%
Adverse Drug Reaction
20%
Gonadorelin Derivative
20%
Medroxyprogesterone
20%
Intradermal Drug Administration
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Gonadorelin Agonist
100%
Anaphylaxis
100%
Gonadorelin
40%
Placebo
20%
Progesterone
20%
Remission
20%
Adverse Drug Reaction
20%
Medroxyprogesterone
20%
Gonadorelin Derivative
20%
Diseases
20%
Immunology and Microbiology
Agonist
100%
Anaphylaxis
100%
Progesterone Release
20%